230 related articles for article (PubMed ID: 8306258)
1. A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies.
Ram S; Buchsbaum DJ
Cancer; 1994 Feb; 73(3 Suppl):769-73. PubMed ID: 8306258
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biodistribution of peptide based 99mTc/186Re-MAGIPG-D612 monoclonal antibody in nude mice bearing colon cancer xenografts.
Ram S; Merriwether W; Buchsbaum DJ
Cancer Biother Radiopharm; 1997 Feb; 12(1):55-62. PubMed ID: 10851448
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination of monoclonal antibodies D612 and 17-1A with 3-iodophenylisothiocyanate and their biodistribution in tumor-bearing nude mice.
Ram S; Buchsbaum DJ
Cancer; 1994 Feb; 73(3 Suppl):808-15. PubMed ID: 8306264
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a new class of isothiocyanatopeptide bifunctional chelating agents for coupling to monoclonal antibodies.
Ram S; Buchsbaum DJ
Int J Pept Protein Res; 1996 Jul; 48(1):79-86. PubMed ID: 8844266
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice.
Goldrosen MH; Biddle WC; Pancook J; Bakshi S; Vanderheyden JL; Fritzberg AR; Morgan AC; Foon KA
Cancer Res; 1990 Dec; 50(24):7973-8. PubMed ID: 2253238
[TBL] [Abstract][Full Text] [Related]
7. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice.
Najafi A; Alauddin MM; Sosa A; Ma GQ; Chen DC; Epstein AL; Siegel ME
Int J Rad Appl Instrum B; 1992 Feb; 19(2):205-12. PubMed ID: 1601674
[TBL] [Abstract][Full Text] [Related]
9. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
[TBL] [Abstract][Full Text] [Related]
13. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
Nucl Med Biol; 1998 Jan; 25(1):37-45. PubMed ID: 9466360
[TBL] [Abstract][Full Text] [Related]
14. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
15. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
[TBL] [Abstract][Full Text] [Related]
16. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand.
Milenic DE; Roselli M; Brechbiel MW; Pippin CG; McMurray TJ; Carrasquillo JA; Colcher D; Lambrecht R; Gansow OA; Schlom J
Eur J Nucl Med; 1998 May; 25(5):471-80. PubMed ID: 9575242
[TBL] [Abstract][Full Text] [Related]
18. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
[TBL] [Abstract][Full Text] [Related]
19. Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.
John E; Thakur ML; DeFulvio J; McDevitt MR; Damjanov I
J Nucl Med; 1993 Feb; 34(2):260-7. PubMed ID: 8429345
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]